Association of WT-<i>IRF8</i> expression (fold-change) with patient characteristics, based on 194 adult patients with previously untreated AML.

P.I. = Pacific Islander; Nat. Amer. = Native American or Alaskan Native; P1 = p-value based on Wilcoxon rank sum test; P2 = p-value from chi-square test for independence (Race, Performance Status, FAB Class, Cytogenetic Risk Group) or Fisher's exact test (Sex, AML Onset, FLT3-ITD); unknown categories are excluded from all significance tests. * = FAB classifications for 14 patients (as reported by treating institutions based on their local pathology) were combined into “Other” FAB class for statistical purposes due to small numbers of patients in each individual FAB class.